I'm saying they should focus on the larger markets for their other drugs.
That's not an unreasonable stance.
Especially since they'll need more studies for covid ARDS, and every person vaccinated is one less person who will need this treatment for it.
You've got this misdirected anger and it's blinding you to sense lopes. Call me a janitor, or a lab tech all you want like those are some sort of insult.
But so far I've been right about MSB the last couple of years, and you've been wrong. So maybe go read some books so you can understand the science like a janitor does
Cell Therapy News/Articles, page-11581
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.045(4.07%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.16 | $1.08 | $4.681M | 4.170M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 99680 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 31000 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |